INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Return on equity 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-49.5%FY2025 · since FY2016: 8.9% → -49.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -49.5% | -49.0 pp |
| FY2024 | -0.4% | -4.7 pp |
| FY2023 | 4.3% | -5.7 pp |
| FY2022 | 10.0% | -0.0 pp |
| FY2021 | 10.0% | +1.2 pp |
| FY2020 | 8.8% | +5.3 pp |
| FY2019 | 3.5% | -0.9 pp |
| FY2018 | 4.4% | -2.3 pp |
| FY2017 | 6.7% | -2.2 pp |
| FY2016 | 8.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Gross marginIART Operating incomeIART Operating marginIART Operating cash flowIART Free cash flowIART Capital expendituresIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →